What Is Filaggrin? The Genetic Path to Atopic Dermatitis

Filaggrin's Dual Function: Structure and NMF

Filaggrin (filament-aggregating protein) takes on two critical functions in the skin barrier. The first function is structural: it cross-links cytokeratin filaments, tightening the cytoskeleton and giving corneocytes their rigidity and flattened-disc shape. Without this structural function, the stratum corneum's physical resistance drops significantly.

The second function is metabolic: during terminal differentiation, filaggrin is broken down by proteases like glutaminase, caspase-14, and cystatin-A into small amino acid derivatives. These breakdown products form NMF (pyrrolidone carboxylic acid, urea, amino acids) and give the stratum corneum its moisture-retention capacity. Without filaggrin, both structure and the moisture reserve break down.

The FLG Mutation: The Genetic Basis of Atopic Dermatitis

FLG null mutations, discovered by Palmer et al. in 2006, have been identified as the strongest genetic risk factor for atopic dermatitis (AD). R501X and 2282del4 are the most common mutation forms in Europe; different mutations (S3247X, 3321delA) dominate in Asian populations. A single copy of an FLG mutation (heterozygous) raises AD risk 3-4 fold, while a double copy (homozygous) raises it 5-7 fold.

The Environmental-Trigger Gateway

An FLG mutation also opens a "gateway" that lets allergic rhinitis, food allergy, and asthma originate through the skin barrier. Barrier breakdown lets allergens and microbial products cross the epidermis; this sensitization triggers the development of respiratory and food allergies — this is the molecular basis of the atopic march theory.

Managing the Barrier Without Knowing Your FLG Status

Genetic testing isn't practical for most people; but even without an FLG mutation, environmental factors can cause a temporary drop in filaggrin. SLS, aggressive scrubs, prolonged exposure to dry air, and frequent face-washing all suppress filaggrin expression.

Topical Support Strategies

For individuals with a known or suspected FLG mutation, barrier management should include: (1) A ceramide-containing emollient, without fail, twice a day. (2) Niacinamide — stimulates filaggrin and ceramide synthesis. (3) The gentlest cleanser possible (low-sulfate or non-ionic surfactant). (4) A humidifier in low-humidity environments. (5) Extreme caution when introducing barrier-irritating actives (high-concentration AHA, retinol).

The CIRÈLL Perspective: A Barrier Protocol Built on Genetic Awareness

From CIRÈLL's scientific editorial perspective, FLG genetics isn't destiny — it's a clue. If an FLG mutation is present, strengthen the barrier first, then add active ingredients. The ceramide + niacinamide + panthenol trio is the foundation of the FLG-compensation protocol. This trio doesn't fully make up for a genetic NMF deficiency, but it's clinically proven to help manage symptoms and reduce the frequency of atopic flares.^{van Smeden et al., 2014}

What Do These Signs Mean for You?

Science explains how skin works, but you probably arrived at this page with a specific question. Here are the most common signs and the reasons behind them:

Applying Filaggrin Science to Daily Skincare

A Personalized Barrier Protocol for FLG Mutation Carriers

A filaggrin gene mutation (FLG) is detected in roughly 30-40% of atopic dermatitis patients, but not everyone who carries the mutation develops atopic dermatitis. The presence of an FLG mutation indicates that the stratum corneum's water-binding capacity is permanently lower, and that barrier-support treatment is a lifelong need. This means barrier care should be built as a continuous habit, not a seasonal or symptom-triggered one.

Priority actives for people with an FLG mutation: ceramide (indirectly compensates for the NMF deficiency caused by the lack of filaggrin), urea (5-10%, boosts stratum corneum flexibility through its humectant and keratolytic effect), panthenol (stimulates epidermal renewal), and probiotic/postbiotic support (keeps the skin microbiome balanced, limiting S. aureus colonization).

FLG and Food Allergy: Signals Beyond the Barrier

According to the cutaneous sensitization hypothesis, a barrier compromised by an FLG mutation presents allergen proteins (peanut, milk, wheat) to the immune system, setting the stage for food allergy. This theory is supported by promising clinical findings suggesting that early proactive emollient treatment may prevent not just eczema, but the development of food allergy as well. Ceramide-based barrier protection starting in infancy has, in this context, become a strategy recommended by both dermatologists and allergists alike.

CIRÈLL's genetic-awareness barrier protocol approaches care for people with an FLG mutation from a proactive rather than reactive perspective. This approach puts both atopic dermatitis management and long-term barrier quality on a systematic footing.

Conclusion

Filaggrin (FLG) is a dual-function barrier protein derived from the profilaggrin precursor — it both binds keratin filaments together and produces NMF; an FLG mutation raises atopic dermatitis risk 3-5 fold.

Understanding the stratum corneum's molecular structure is the foundation for choosing the right barrier support. CIRÈLL's Biomimetic TriBarrier system supports both NMF components and ceramide lipids together, delivering comprehensive barrier repair.

Frequently Asked Questions